Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases
{{output}}
Introduction: The large-scale approval of anti-amyloid monoclonal antibodies for treating Alzheimer's disease (AD) has raised concerns about their safety due to treatment-emergent amyloid-related imaging abnormalities (ARIA). ... ...
